Chargement en cours...
Apatinib as an optional treatment in metastatic colorectal cancer
Antiangiogenic therapy has shown clinical benefit in metastatic colorectal cancer (mCRC). We aimed to evaluate the efficacy and safety of apatinib in patients who failed standard treatment and to explore potential factors related to its efficacy. A total of 47 patients were enrolled in this retrospe...
Enregistré dans:
| Publié dans: | Medicine (Baltimore) |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Health
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736175/ https://ncbi.nlm.nih.gov/pubmed/31464927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016919 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|